In his first press conference as president-elect, Donald Trump insisted pharma was “getting away with murder” due to expensive drug prices.
Print Issue: January 01, 2018
Flexion’s pivot proves pain-free
Clayman says the company’s next 18 months are all about Zilretta, with further pipeline construction next up.
Back to the Future: Print media thrives in point of care
Not only isn’t print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it’s thriving in a most unlikely environment: the point of care
Machine Learning Can Decipher Data
As researchers and analysts, we interact with a wide array of market research pros in the health and wellness space.
New tactics change clinical trial awareness game
Recruitment for clinical trials has never been easy. New tools and tactics could change that — assuming the sheer volume of information doesn’t overwhelm trial organizers.
Infographic | Docs, payers need pharma to step up
For all the talk about new and better ways to engage, pharma still hasn’t created an appreciably higher volume of satisfied — or informed — customers.
No Google, no problem: Pharma partners with China’s tech giants
In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China’s tech giants to snare a slice of a more than $100 billion market
Taxpayers Need to Cough up the Cash to Keep Federal Agencies Afloat
As we continue to debate the proper size and role of government in society, cast your eyes on recent polls by Gallup and Pew that found the majority of Americans felt their income tax was fair.
The buyer’s guide to pharma, healthcare, and life sciences consultancies
Do the healthcare and pharma arms of Accenture, Deloitte, PwC, and other consultancies pose an existential threat to traditional healthcare agencies?
